HighTower Advisors, LLC - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 169 filers reported holding BRIDGEBIO PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.7%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$5,253,000
+36.7%
199,236
-10.9%
0.01%
+25.0%
Q2 2023$3,844,000
+11.2%
223,613
+7.2%
0.01%0.0%
Q1 2023$3,457,000
+117.7%
208,613
+0.1%
0.01%
+100.0%
Q4 2022$1,588,000
-23.3%
208,3850.0%0.00%
-33.3%
Q3 2022$2,071,000
+9.5%
208,3850.0%0.01%
+20.0%
Q2 2022$1,891,000
-10.6%
208,385
+0.1%
0.01%0.0%
Q1 2022$2,115,000
-42.1%
208,270
-4.9%
0.01%
-37.5%
Q4 2021$3,652,000
-63.2%
218,922
+3.4%
0.01%
-70.4%
Q3 2021$9,920,000
-26.6%
211,638
-4.6%
0.03%
-30.8%
Q2 2021$13,520,000
-1.0%
221,768
+0.0%
0.04%
-9.3%
Q1 2021$13,661,000
-12.8%
221,765
+0.6%
0.04%
-33.8%
Q4 2020$15,672,000
+89.6%
220,408
+0.0%
0.06%
+62.5%
Q3 2020$8,267,000
+15.1%
220,3080.0%0.04%
+2.6%
Q2 2020$7,184,000
+12.4%
220,3080.0%0.04%
-4.9%
Q1 2020$6,390,000220,3080.04%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$100,609,51348.41%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$514,990,89915.50%
M28 Capital Management LP 304,700$5,051,9265.71%
Cormorant Asset Management, LP 4,557,414$75,5624.98%
Octagon Capital Advisors LP 1,338,160$22,186,6933.19%
Ikarian Capital, LLC 594,686$9,859,8942.24%
Affinity Asset Advisors, LLC 389,800$6,462,8842.13%
VIKING GLOBAL INVESTORS LP 26,620,991$441,376,0312.07%
Ikarian Capital, LLC 549,600$9,112,3682.07%
Affinity Asset Advisors, LLC 320,000$5,305,6001.75%
View complete list of BRIDGEBIO PHARMA INC shareholders